Results 271 to 280 of about 1,514,743 (364)

Burden and Trends of Common Oral Disorders Across the Association of Southeast Asian Nations From 1990 to 2021. [PDF]

Int Dent J
Cao Y, Wong RCW, Jansisyanont P, Hariri F, Amir LR, Segarra MS, Zheng L.   +6 more
europepmc   +1 more source

Fixed‐Duration Subcutaneous Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma: Pivotal Phase 2 Primary Analysis

American Journal of Hematology, EarlyView.
ABSTRACT Mosunetuzumab is approved as an intravenous (IV) formulation for relapsed/refractory (R/R) follicular lymphoma (FL) after ≥ 2 prior therapies. A subcutaneous (SC) formulation, aiming to improve patient safety and convenience, has been developed.
Nancy L. Bartlett, Laurie H. Sehn, Sarit Assouline, Pratyush Giri, John Kuruvilla, Stephen J. Schuster, Sung‐Soo Yoon, Keith Fay, Georg Hess, Martin Dreyling, Norma C. Gutierrez, Eva Cybulski, Fidelis Sabalvaro, Elicia Penuel, Vanda Teodoro, Samuel Tracy, Denison Kuruvilla, Joseph Chen, Volker Wiebking, Michael C. Wei, L. Elizabeth Budde   +20 more
wiley   +1 more source

Trends in 5-year community management of persons with dementia in Korea, 2003-2016. [PDF]

PLoS One
Sung W, Kwon HS, Suh J, Koh IS, Park KU, Choi H.   +5 more
europepmc   +1 more source

Kazakhstani immigration policy impact for ethno-demographic structural changes

, 2019
Amangul Shugatai
openalex   +2 more sources

Real‐World Effectiveness and Safety of Ravulizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria: Evidence From the International PNH Registry

American Journal of Hematology, EarlyView.
ABSTRACT Ravulizumab, a second‐generation complement component 5 inhibitor (C5i) derived from eculizumab, with improved pharmacokinetics, is the current standard‐of‐care treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH), where available.
Alexander Röth, Christopher J. Patriquin, Jeff Szer, Louis Terriou, Ami S. Patel, Jesse Metzger, Philippe Gustovic, Jun‐ichi Nishimura, Robert A. Brodsky   +8 more
wiley   +1 more source

In the wake of USAID cuts, we can create a Demographic and Health Survey Program founded on more equitable data infrastructure and stronger research integrity. [PDF]

Proc Natl Acad Sci U S A
Abdel Ghany J, Nur AA, MacQuarrie KLD, Wilde J, Sully EA, Karra M, Gazeley U, John BM, Montana L.   +8 more
europepmc   +1 more source

Poverty and Population: Numbers, Rates of Change, Demographic, Patterns, Policies

, 1998
Reginald H. Green
openalex   +1 more source

Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex

American Journal of Hematology, EarlyView.
ABSTRACT The epidemiology of myelodysplastic syndromes/neoplasms (MDS) is challenging to define due to inconsistent reporting, complex diagnostic procedures, and evolving diagnostic criteria. Using the National MDS Natural History Study—a prospective cohort with centrally adjudicated histopathology and genetic variant review—we characterized the ...
Nancy Gillis, Christelle Colin‐Leitzinger, Yi‐Han Tang, Michael Otterstatter, Seth Sherman, Ling Zhang, Lynn C. Moscinski, Mary Ellen Walker, Jeffrey S. Painter, Gregory A. Abel, Tareq Al Baghdadi, H. Joachim Deeg, James M. Foran, Steven D. Gore, Alexandra M. Harrington, Steven H. Kroft, Jane Jijun Liu, Wael Saber, Shamsuddin Virani, Rafael Bejar, R. Coleman Lindsley, Eric Padron, Matthew J. Walter, Rami Komrojki, Amy E. DeZern, Mikkael A. Sekeres   +25 more
wiley   +1 more source

Priscilla Idele: fertility, choice and changing norms. [PDF]

Bull World Health Organ
europepmc   +1 more source

Patient satisfaction with cross-boundary healthcare: a cross-sectional study of Hong Kong residents' healthcare utilization in mainland China. [PDF]

BMC Health Serv Res
Zhu Y, Yan X, Han Z, He S.
europepmc   +1 more source